Insider Transactions and Holdings
-
Entity Type
-
Company
-
Role
-
Director
-
Stock Symbol
-
SYRE on Nasdaq
There are no Buy or Sell transactions made by Fairmount Funds Management LLC since 11/21/2024
Holdings reported by Fairmount Funds Management LLC for Spyre Therapeutics, Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Stock Option (Right to Buy) |
25K |
|
|
May 29, 2025 |
By Peter Harwin |
Common Stock |
|
| Stock Option (Right to Buy) |
25K |
|
|
May 29, 2025 |
By Tomas Kiselak |
Common Stock |
|
Transactions reported by Fairmount Funds Management LLC for Spyre Therapeutics, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.